NCT05155787

Brief Summary

The purpose of this study is to evaluate the effects of NFT on sleep quality and cognitive-behavioral performance among HIV-infected patients, to use it as a reference for the construction of NFT as a clinical empirical treatment model for HIV-infected patients with sleep disturbance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 4, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

December 14, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

May 22, 2025

Status Verified

July 1, 2023

Enrollment Period

2.4 years

First QC Date

April 4, 2021

Last Update Submit

May 19, 2025

Conditions

Keywords

neurocognitive performance, neurofeedback training

Outcome Measures

Primary Outcomes (4)

  • Subjective sleep quality as assessed by Chinese version Pittsburgh Sleep Quality Index (CPSQI)

    Subjective sleep quality was measured by Chinese version of the Pittsburgh Sleep Quality Index (CPSQI). A patient with a score of \>=5 would be identified as poor sleep quality.

    1 month

  • The length of minutes of total sleep time (TST) as assessed by the acti-watch

    This objective outcome measures by the acti-watch (Axivity, Newcastle, UK), which contains an accelerometer for detection of movement, produces a continuous electrical signal (voltage) when a participant wore the device for up to one month. Total sleep time (TST): TST referred to as the true sleep period, is defined as the interval (within time in bed) from sleep onset to sleep offset.

    1 month

  • The length of minutes of sleep onset latency (SOL) as assessed by the acti-watch

    This objective outcome measures by the acti-watch (Axivity, Newcastle, UK), which contains an accelerometer for detection of movement, produces a continuous electrical signal (voltage) when a participant wore the device. Sleep onset latency (SOL): SOL refers to the number of minutes it took a subject to fall asleep. It is the number of minutes between lying down in bed and actually falling asleep.

    1 month

  • The percentage of sleep efficiency (SE) as assessed by the acti-watch

    This objective outcome measures by the acti-watch (Axivity, Newcastle, UK), which contains an accelerometer for detection of movement, produces a continuous electrical signal (voltage) when a participant wore the device for up to one month. Sleep efficiency (SE): SE is defined as the percentage of time spent asleep during the time in bed. SE is derived as follows: SE=(TST/time in bed)×100%.

    1 month

Secondary Outcomes (1)

  • Cognitive performance as assessed by the International HIV dementia scale (IHDS)

    1 month

Study Arms (2)

Group with neurofeedback training

EXPERIMENTAL

The neurofeedback training system records the brain waves from the subject and converts the original brain wave signal into frequency energy through spectrum analysis. The system will help the subject to find self relax method for producing more alpha waves. Each person will arrange training three times a week for four weeks.

Device: Neurofeedback

Group with shame neurofeedback training

SHAM COMPARATOR

In the shame group, the system is not feedback to the actual wave. Each person will arrange training three times a week for four weeks.

Device: Shame neurofeedback

Interventions

Neurofeedback training as a method is going to let the brain producing the alpha signal (8-13 Hz).

Group with neurofeedback training

shame neurofeedback

Group with shame neurofeedback training

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-infected persons

You may not qualify if:

  • Patients with central neural infections
  • Pregnant women
  • Drug or alcohol abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

Tainan, Taiwan, 704, Taiwan

Location

Related Publications (3)

  • Alford K, Banerjee S, Nixon E, O'Brien C, Pounds O, Butler A, Elphick C, Henshaw P, Anderson S, Vera JH. Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV. Brain Sci. 2019 Feb 8;9(2):37. doi: 10.3390/brainsci9020037.

    PMID: 30744034BACKGROUND
  • Cicerone KD, Goldin Y, Ganci K, Rosenbaum A, Wethe JV, Langenbahn DM, Malec JF, Bergquist TF, Kingsley K, Nagele D, Trexler L, Fraas M, Bogdanova Y, Harley JP. Evidence-Based Cognitive Rehabilitation: Systematic Review of the Literature From 2009 Through 2014. Arch Phys Med Rehabil. 2019 Aug;100(8):1515-1533. doi: 10.1016/j.apmr.2019.02.011. Epub 2019 Mar 26.

    PMID: 30926291BACKGROUND
  • Gamaldo CE, Gamaldo A, Creighton J, Salas RE, Selnes OA, David PM, Mbeo G, Parker BS, Brown A, McArthur JC, Smith MT. Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):609-16. doi: 10.1097/QAI.0b013e31829d63ab.

    PMID: 23722610BACKGROUND

MeSH Terms

Conditions

HIV Infections

Interventions

Neurofeedback

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Head Nurse and Clinical Assistant Professor

Study Record Dates

First Submitted

April 4, 2021

First Posted

December 14, 2021

Study Start

March 1, 2021

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

May 22, 2025

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations